| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
High Susanna Gatti is a Chief Operating Officer at Dyne Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 9,939 | $7.40 | $73,548.60 | -9.5% | +199.3% | +302.0% | |
| Sep 18, 2023 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 2,672 | $9.41 | $25,143.52 | -2.5% | +21.1% | +251.3% | |
| Sep 12, 2023 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 1,635 | $10.41 | $17,020.35 | -1.5% | +10.1% | +229.3% | |
| Jun 13, 2023 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 1,625 | $12.43 | $20,198.75 | -1.5% | -13.1% | +156.5% | |
| Mar 14, 2023 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 1,559 | $13.33 | $20,781.47 | -1.4% | -7.3% | +105.7% | |
| Dec 12, 2022 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 751 | $10.87 | $8,163.37 | -0.7% | +13.1% | -5.9% | |
| Mar 11, 2022 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 765 | $8.73 | $6,678.45 | -1.0% | -38.6% | +49.8% | |
| Sep 23, 2021 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 2,451 | $17.22 | $42,206.22 | -6.8% | -27.2% | -27.2% |